Abstract:Objective:Casein kinase Ⅱ is also called protein kinase CK2. This study was to explore the mRNA expression and enzyme activity of CK2 alpha, alpha’ and beta subunits in the tissues of non-small cell lung cancer (NSCLC), and investigate their correlations with clinicopathologic features of NSCLC. Methods: Immunohistochemical method (SP) was used to examine the expression of CK2 alpha, alpha’ and beta subunits in paraffin-embedded speciments of 7 benign lesions, 35 primary lung carcinomas and matched pericancerous tissues. The mRNA expressions of CK2 subunits were evaluated by reverse transcription-polymerase chain reaction (RT-PCR) in 4 benign lesions, 10 primary lung carcinomas and matched peritumor tissues and the activity of CK2 was measured by using isotope incorporation assay. Results:The positive rates of CK2 alpha and beta subunits (62.9% and 57.1%) were significantly higher in NSCLC tissues than those in matched adjacent noncancerous tissues (11.4% and 25.7%, P0.05) and benign lesions tissues (28.6% and 42.9%, P0.05). The positive rate of CK2 alpha’ subunit (65.7%) was higher in NSCLC tissues than that in matched adjacent noncancerous tissues and benign lesions tissues (42.9% and 42.9%, P0.05). The expression levels of CK2 subunits had no correlation with gender, age, and pathologic stage (TNM) of the patients (P0.05). The expression level of CK2 alpha’ subunit was not related with cell differentiation and histological classification; the expression level of CK2 alpha subunit was associated with cell differentiation (r=0.388, P0.05) but not related with histological classification. The positive rate of CK2 alpha subunit was significantly higher in poorly differentiated group than that in moderately differentiated and well-differentiated groups (P0.05). The positive rate of CK2 beta subunit was significantly higher in squamous cell carcinoma than that in adenocarcinoma (P0.05) but it was not related with the degree of cell differentiation. The expression level of CK2 beta subunit positively correlated with that of CK2 alpha or alpha’ subunit in NSCLC (r=0.439, P0.05;r=0.45, P0.05). The mRNA expression levels of the three CK2 subunits were higher in lung tumors compared with the corresponding pericancerous lung tissues and non-tumor benigh lesions tissues. The ave-rage activity of CK2 in the lung carcinomas was 5.4-fold higher than that in matched adjacent noncancerous tissues and 3.6-fold higher than that in benign lesion tissues. Conclusion:Protein kinase CK2 subunits are highly expressed in NSCLC and their overexpression have correlation with the tumorigenesis and development of NSCLC. As a biological marker, CK2 alpha or beta subunit may be better than CK2 alpha’.

[Expression and Clinical Significance of Ku70, Ku80 and DNA-PKcs Proteins in Patients with Stagei-Ii Non-Small Cell Lung Cancer by Tissue Microarray].

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Prognostic Significance of Ataxia-Telangiectasia Mutated, DNA-dependent Protein Kinase Catalytic Subunit, and Ku Heterodimeric Regulatory Complex 86-Kd Subunit Expression in Patients with Nonsmall Cell Lung Cancer.

Expression of ATM , CHK 2 and BRCA 1 predicts the clinical outcome of non-small cell lung cancer in patients receiving platinum-based chemotherapy

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.

Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy

[Expression of PTEN, p16, p21, and p53 proteins in lung cancer using tissue microarray and their clinical significance]

Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters.

Expression of Nuclear Factor-Kappa B and Its Clinical Significance in Nonsmall-Cell Lung Cancer

Expression Of Ki-67 And Pakt In Colorectal Cancer Tissues And Their Clinical Significance

E Xpression of DNA-PKcs and Its Clinicopathological Significance in Invasive Breast Cancer

[Epidermal Growth Factor Receptor and Phosphorylated Akt Protein Expression in Non-Small-cell Lung Cancer].

Expressions and clinical significance of varied membrae transport proteins in patients with early non-small cell lung cancer

The abnormal expression and the clinicopathologic significance of Polo-like kinase 1 ( PLK1 ) in adenocarcinoma of the lung

Expression Of Ercc1 And Class Iii Beta-Tubulin In Resected Non-Small Cell Lung Cancer And Its Correlation With Platinum-Based Adjuvant Chemotherapy

[The Current Immunohistochemistry Markers in the Resected Tissues of Non-small Cell Lung Cancer Could Not Predict Prognosis].

Relationship between expression of multidrug resistance protein,PCNA and p53 and its significance in patients with non-small cell lung cancer

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer

Expression of Protein Kinase CK2 Subunits in Non-Small-cell Lung Cancer Tissues and Its Significance

The Expression and Prognosis for Aurora kinases in Human non-small cell lung cancer